Developmental Disabilities (Developmental Disability)

Subscribe to Selected New Research on Developmental Disabilities

235 relevant articles (8 outcomes, 38 trials/studies) found for this Disease

Description: Disorders in which there is a delay in development based on that expected for a given age level or stage of development. These impairments or disabilities originate before age 18, may be expected to continue indefinitely, and constitute a substantial impairment. Biological and nonbiological factors are involved in these disorders. (From American Psychiatric Glossary, 6th ed)

Also Known As:

Developmental Disability; Child Development Disorders; Disabilities, Developmental; Development Disorders, Child; Child Development Deviation; Child Development Disorder; Development Deviation, Child; Development Deviations, Child; Development Disorder, Child; Developmental Delay Disorder; Deviation, Child Development; Disability, Developmental; Child Development Deviations; Child Development Disorders, Specific; Developmental Delay Disorders

Relationship Network

Disease Context: Research Results

Mental Disorders: 1709

Mental Disorders Diagnosed in Childhood

Developmental Disabilities: 235

Related Diseases

1.	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
2.	Sialorrhea
3.	Bipolar Disorder (Mania)
4.	Mental Retardation (Idiocy)
5.	Autistic Disorder (Autism)

Experts

1.	Hellings, Jessica A: 2 articles (06/2006 - 07/2004)
2.	Zarcone, Jennifer R: 2 articles (07/2004 - 07/2002)
3.	Schroeder, Stephen R: 2 articles (07/2004 - 07/2002)
4.	Heller, Tamar: 2 articles (06/2003 - 01/2002)
5.	Perlman, Steven P: 2 articles (09/2002 - 06/2002)
6.	Waldman, H Barry: 2 articles (09/2002 - 06/2002)
7.	Glick, Norris R: 1 article (08/2008)
8.	Fischer, Milton H: 1 article (08/2008)
9.	Guay, Guay Rp: 1 article (12/2007)
10.	Guay, David R P: 1 article (12/2007)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Developmental Disabilities:

1.	Risperidone (Risperdal Consta)FDA Link 11/01/2001 - "The efficacy of the atypical antipsychotic risperidone was evaluated in the treatment of aberrant behavior (e.g., aggression, self-injury) in 20 individuals with developmental disabilities" 08/01/2002 - "This study evaluated the wide range of effects of risperidone on destructive behavior of 2 persons with developmental disabilities using weekly functional analysis sessions, daily observations, hourly home data, weekly rating scales, and monthly psychiatric impressions" 07/01/2004 - "Effects of risperidone on destructive behavior of persons with developmental disabilities: III. Functional analysis." 05/01/2003 - "Reader response to, "Effects of risperidone on aberrant behavior in persons with developmental disabilities: I. A double-blind crossover study using multiple measures"." 08/01/2002 - "Risperidone, an atypical neuroleptic, has become a popular option for treating destructive behaviors of persons with developmental disabilities" Order ALL the reference details at left...
2.	MelatoninIBA 08/01/2001 - "This study explored the safety and efficacy of synthetic melatonin in the treatment of sleep problems in 20 children with developmental disabilities, in a randomized, double-blind, placebo-controlled 6-week trial of melatonin versus placebo" 08/01/2001 - "This study suggests that synthetic melatonin reduces sleep latency in children with developmental disabilities." 11/01/2003 - "Melatonin supplementation for severe and intractable sleep disturbance in young people with genetically determined developmental disabilities: short review and commentary." 08/01/2001 - "Melatonin for treatment of sleep disorders in children with developmental disabilities." Order ALL the reference details at left...
3.	Methylphenidate (Ritalin)FDA LinkGeneric 07/01/1999 - "Efficacy of methylphenidate among preschool children with developmental disabilities and ADHD." 07/01/1999 - "OBJECTIVE: This was a double-blind, placebo-controlled, crossover design study of the safety and efficacy of methylphenidate (MPH) in 11 preschool children (aged 4.0-5.11 years) with developmental disabilities and attention-deficit hyperactivity disorder (ADHD)" Order ALL the reference details at left...
4.	Clozapine (Clozaril)FDA LinkGeneric 05/01/2006 - "Clozapine is the most effective antipsychotic medication currently in use, but there has been a paucity of well-controlled research on its efficacy with people with developmental disabilities" 05/01/2006 - "We provide recommendations regarding the use of clozapine that are based on three main sources: literature and published professional practice guidelines regarding the use of clozapine in individuals who do not have developmental disabilities, the limited literature on the use of clozapine in individuals who have developmental disabilities, and our own clinical experience" 05/01/2006 - "Guidelines for the use of clozapine in individuals with developmental disabilities." 11/01/2003 - "Nothing new under the sun: clozapine rechallenge following a life-threatening medical event in a patient with psychiatric illness and developmental disability." 05/01/2006 - "We present a set of guidelines to ensure proper utilization of clozapine in individuals with developmental disabilities, because it can offer them therapeutic advantages similar to those observed in people with schizophrenia" Order ALL the reference details at left...
5.	Valproic Acid (Valproate, Semisodium)FDA LinkGeneric 06/01/1987 - "There are inadequate data to assess the magnitude, if any, of the risks for postnatal growth abnormalities and developmental disabilities associated with the use of valproic acid during pregnancy" 06/01/2006 - "Much improved outcome with gabapentin-divalproex combination in adults with bipolar disorders and developmental disabilities." Order ALL the reference details at left...
6.	Psychotropic Drugs (Psychoactive Drugs)IBA 09/01/1993 - "Efficacy of psychotropic drugs for reducing self-injurious behavior in the developmental disabilities." Order ALL the reference details at left...
7.	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 12/01/2000 - "CONCLUSIONS: Glycopyrrolate is effective in the control of excessive sialorrhea in children with developmental disabilities" Order ALL the reference details at left...
8.	gabapentin (Neurontin)FDA LinkGeneric 06/01/2006 - "Much improved outcome with gabapentin-divalproex combination in adults with bipolar disorders and developmental disabilities." Order ALL the reference details at left...
9.	Antipsychotic Agents (Antipsychotics)IBA 12/01/2004 - "The objective of this study was to develop an assessment battery to describe the effects of traditional neuroleptics on the behavior and movements of a small sample of children and adolescents with mental retardation and other developmental disabilities" 10/01/2001 - "OBJECTIVE: To study the usage, efficacy, and side effects patterns of atypical neuroleptics (atypicals) in adolescents and young adults with developmental disabilities (DDs) (mental retardation)" 06/01/1989 - "Based upon this study and a larger study of 4,649 individuals with developmental disability, we recommend that clinicians carefully evaluate for tardive dyskinesia any individuals with developmental disability who have been prescribed antipsychotics for greater than 3 months and who score 6 or above on the DISCUS." 12/01/2004 - "The effects of traditional neuroleptics on a comparable population of children and adolescents with mental retardation and other developmental disabilities are unknown" 12/01/2004 - "Although the risk of the eventual development of tardive dyskinesia and other persistent adverse effects of neuroleptics is high, among adults with mental retardation and other developmental disabilities, neuroleptics may ameliorate dyskinesias, aggression, and inattention" Order ALL the reference details at left...
10.	Carbon MonoxideIBA 08/01/2008 - "This study examined health behaviors, utilization, and access to care among older Latina and Black American mothers who co-reside with a child with developmental disabilities" 09/01/2008 - "The presence of co-occurring psychiatric disorders among individuals with developmental disability (DD) requires clinicians to adjust and modify standard mental health assessment and treatment planning" 06/01/2006 - "We used the National Health Interview Survey to compare the health of older mothers who were co-residing with a child who had a developmental disability to the health of same age mothers without caregiving responsibilities" 01/01/2002 - "Developmental language learning impairments (LLI) are one of the most prevalent of all developmental disabilities, can occur in children for a wide variety of reasons, and have been shown to co-occur frequently with other developmental social, emotional and behavioral disorders, as well as with academic achievement problems" 01/01/2002 - "Service utilization patterns were not consistent within types of developmental disability, suggesting that formal and co-ordinated interdisciplinary programmes are not in place for this population of interest." Order ALL the reference details at left...

Therapies and Procedures

1.	General Anesthesia 01/01/1998 - "The purpose of this study was to determine the impact and limitations that an incomplete medical assessment may present in the delivery of dental care under general anesthesia to these adults with developmental disability" 01/01/1998 - "Adults with developmental disabilities can be safely managed under general anesthesia for dental treatment in a hospital setting with minimal morbidity and without extensive preoperative investigations." 01/01/1998 - "General anesthesia for the provision of dental treatment to adults with developmental disability." 07/01/2005 - "This study tested whether the use of a reinforced laryngeal mask airway (LMA) compared to endotracheal intubation (El) anesthesia diminished adverse events and improved the post-operative quality of life for 146 dental patients who required general anesthesia due to developmental disabilities" Order ALL the reference details at left...
2.	Anesthesia 07/01/2005 - "This study tested whether the use of a reinforced laryngeal mask airway (LMA) compared to endotracheal intubation (El) anesthesia diminished adverse events and improved the post-operative quality of life for 146 dental patients who required general anesthesia due to developmental disabilities" 11/01/2005 - "PATIENTS: One hundred ten ASA physical status I and II ambulatory patients with moderate developmental disabilities who received anesthesia for dental care" 11/01/2005 - "CONCLUSION: Emergence agitation may be reduced by using 1 to 1.5 microg/kg of fentanyl during induction while maintaining anesthesia by sevoflurane in patients with moderate developmental disabilities undergoing dental care, without causing an increase in postoperative adverse effects and affecting the patient's life quality after discharge." Order ALL the reference details at left...
3.	Long-Term Care 01/01/2006 - "This paper describes a qualitative study of factors affecting decisions about use of Medicaid-funded long-term care (LTC) services in Arkansas for the elderly (aged 65+), non-elderly adults with physical disabilities (aged 21-64), and adults with developmental disabilities (aged 18+)" 01/01/1990 - "Cost studies in the long-term care field are reviewed, with emphasis on those relating to people with developmental disabilities" 12/01/2005 - "A substantially greater share of long-term-care dollars supports community-based care for individuals with intellectual and developmental disabilities, relative to older and working-age persons with primarily physical disabilities" 10/01/2005 - "Factors, such as limited existing long-term care resources, increased life expectancy for people with developmental disabilities, changing family demographics, legal actions, and competition for resources with the elderly population are driving the crisis" 10/01/2005 - "There is an impending crisis in long-term care for people with developmental disabilities" Order ALL the reference details at left...
4.	Occupational Therapy (Therapy, Occupational) 12/01/2008 - "This study indicates the importance of illustrating experiences of ethical dilemmas within occupational therapy praxis and the meaning of discussing ethical dilemmas with different healthcare providers to reach a divided view of the client in order to develop successful and healthy strategies that will optimize the rehabilitation of clients with developmental disabilities." 03/01/1992 - "This study demonstrates the long-term effectiveness of occupational therapy when specific treatment goals are matched with individualized training sequences for persons with developmental disabilities." 02/01/2008 - "BACKGROUND: For occupational therapy to be meaningful for all families who have a child with a developmental disability, the profession needs to consider and integrate into practice alternative and more inclusive epistemologies" 01/01/2008 - "The COPM was a valuable tool in guiding and measuring the client-centred occupational therapy for children with developmental disabilities" 01/01/2008 - "The application of client-centred occupational therapy for Korean children with developmental disabilities." Order ALL the reference details at left...
5.	Activities of Daily Living (ADL) 12/01/2000 - "DATA SOURCES: Literature in social health, social psychiatry, developmental disabilities, independent living, gerontology, medical rehabilitation, and quality of life studies" 10/01/1986 - "This study examined whether occupational therapists were using treatment time to prepare adults with developmental disabilities for independent living opportunities" 11/01/2005 - "People with developmental disabilities have problems with major life activities such as language, mobility, learning, self-help, and independent living" 11/01/2003 - "BACKGROUND: Since clients with different types of developmental disabilities often experience difficulties in activities of daily living (ADL), it is critical that assessments of ADL are evaluated in order to ensure that one can make valid judgements based on the results of the appraisal" 11/01/2003 - "Validity of a performance assessment of activities of daily living for people with developmental disabilities." Order ALL the reference details at left...

Best Treatments:
Research Summary Report
on Developmental Disabilities

*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 8 Outcomes
Top 200 Key Drugs and Biologics
Top 42 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>